StoryFunding
Lila Sciences reported in talks for $2B Series B at $8.5B valuation, backed by CalPERS and NVentures
Lila Sciences was reported to be in talks for approximately $2 billion in Series B financing at a pre-money valuation of roughly $8.5 billion, with the round anchored by CalPERS and NVIDIA's NVentures. The expansion would support deployment of AI Science Factories across pharma, materials, chemicals, energy and defense.
- Series B of $2 billion at $8.5 billion pre-money valuation, implying $10.5 billion post-money
- Anchored by California Public Employees' Retirement System (CalPERS) and NVentures
- Lila has not officially announced Series B closure as of October 2026
- Total prior funding: $550 million across seed and Series A